Upgrade to SI Premium - Free Trial

HVO (HVO)

0.00 -54.44 (100.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London June 8, 2026 8:00 AM - PR NewsWire Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic June 1, 2026 7:00 AM - PR NewsWire Full Article List